{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001173","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-08-31T20:06:57+00:00","discovered_at":"2026-08-31T20:08:01.690611+00:00","generated_at":"2026-08-31T20:08:13.955471+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Endovia touts federal Schedule III support; CannEpil FDA submission due next week","bullets":["Federal government voiced support during DEA hearings for moving marijuana to Schedule III; Endovia calls it a policy shift.","Endovia expects to submit CannEpil® pre-submission conference request to FDA in the coming week.","Company is evaluating additional cannabinoid formulations/IP for licensing, acquisition, or collaboration.","Working with capital partners to finalize expanded financing for development and potential deals."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001173","json":"https://secwatch.observer/filing/0001731122-26-001173.json","markdown":"https://secwatch.observer/filing/0001731122-26-001173.md","text":"https://secwatch.observer/filing/0001731122-26-001173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001173/0001731122-26-001173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001173/e7903_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T20:08:13.955471+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}